Lantz Keri 4
4 · ACHILLION PHARMACEUTICALS INC · Filed Jan 25, 2019
Insider Transaction Report
Form 4
Lantz Keri
See Remarks
Transactions
- Award
Stock Option (Right to buy)
2019-01-23+100,000→ 100,000 totalExercise: $2.18Exp: 2029-01-23→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]This option vests as to 25% of the original number of shares on the first anniversary of the grant date and as to an additional 6.25% of the original number of shares at the end of each successive three-month period thereafter.